Lectin‐like Oxidized Low‐density Lipoprotein Receptor‐1, a New Promising Target for the Therapy of Atherosclerosis?
- 1 June 2007
- journal article
- review article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 25 (2), 146-161
- https://doi.org/10.1111/j.1527-3466.2007.00009.x
Abstract
Endothelial activation and dysfunction induced by oxidized modified low-density lipoprotein (ox-LDL) is one of the key steps in the initiation of atherosclerosis. Recent studies have shown that a new lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) mediates the recognition and internalization of ox-LDL. LOX-1 is the main receptor for ox-LDL and may play an important role in the pathogenesis of hypertension, diabetes, and, especially, of atherosclerosis. The potential role of LOX-1 in the pathogenesis of atherosclerosis includes: endocytosis of ox-LDL, expression co-location with atherosclerosis enhanced by atherosclerosis-related risk factors, elevated LOX-1 protein in cardiovascular disease, effects related to atherosclerosis and eliminated by antiatherosclerotic drugs. Identification and regulation of LOX-1 and understanding its signal transduction pathways might improve our insight toward the pathogenesis of atherosclerosis and provide a selective treatment approach. LOX-1 might be a potential and promising target for the development of novel antiatherosclerotic drugs. However, due to limited knowledge about LOX-1, there are still many questions to be answered.Keywords
This publication has 98 references indexed in Scilit:
- Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-γBiochemical and Biophysical Research Communications, 2006
- Cross-talk between dyslipidemia and renin–angiotensin system and the role of LOX-1 and MAPK in atherogenesis: Studies with the combined use of rosuvastatin and candesartanAtherosclerosis, 2006
- Channel Blockers Reduce Angiotensin II-Induced Superoxide Generation and Inhibit Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in Endothelial CellsHypertension Research, 2006
- Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damageClinical and Experimental Nephrology, 2004
- OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTIONClinical and Experimental Pharmacology and Physiology, 2004
- Herpes Simplex Virus 1 Induced LOX-1 Expression in an Endothelial Cell Line, ECV 304Viral Immunology, 2004
- Inhibition of LOX-1 by Statins May Relate to Upregulation of eNOSBiochemical and Biophysical Research Communications, 2001
- Accumulation of LOX-1 Ligand in Plasma and Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits: Identification by a Novel Enzyme ImmunoassayBiochemical and Biophysical Research Communications, 2001
- Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) in AtherogenesisTrends in Cardiovascular Medicine, 2001
- Expression of lectin‐like oxidized low density lipoprotein receptor‐1 in human and murine macrophages: upregulated expression by TNF‐αFEBS Letters, 1998